
Sign up to save your podcasts
Or


CFRA’s Todd Rosenbluth recaps ETFs at the halfway point of the year, covering everything from Vanguard’s domination to DFA’s entrance into the space. ETF.com’s Drew Voros offers perspective on 2020’s ETF launches and closures, including highlighting several new Covid-inspired offerings. ETFMG’s Sam Masucci discusses the recently launched ETFMG Treatments, Testing, & Advancements ETF (GERM).
By Nate Geraci4.5
6464 ratings
CFRA’s Todd Rosenbluth recaps ETFs at the halfway point of the year, covering everything from Vanguard’s domination to DFA’s entrance into the space. ETF.com’s Drew Voros offers perspective on 2020’s ETF launches and closures, including highlighting several new Covid-inspired offerings. ETFMG’s Sam Masucci discusses the recently launched ETFMG Treatments, Testing, & Advancements ETF (GERM).

521 Listeners

2,170 Listeners

1,999 Listeners

946 Listeners

104 Listeners

289 Listeners

798 Listeners

2,022 Listeners

194 Listeners

2,154 Listeners

935 Listeners

83 Listeners

86 Listeners

114 Listeners

828 Listeners